Picton Mahoney Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-57,259
Closed -$9.97M – 1333
2025
Q4
$9.97M Buy
57,259
+5,656
+11% +$1.03M 0.08% 208
2025
Q3
$7.43M Sell
51,603
-34,001
-40% -$4.17M 0.07% 232
2025
Q2
$8.62M Buy
85,604
+35,820
+72% +$2.74M 0.09% 205
2025
Q1
$3.8M Buy
49,784
+887
+2% +$67.8K 0.07% 209
2024
Q4
$3.37M Buy
48,897
+3,354
+7% +$242K 0.07% 208
2024
Q3
$3.33M Sell
45,543
-28,249
-38% -$2.08M 0.11% 187
2024
Q2
$4.95M Buy
+73,792
New +$2.86M 0.19% 157
2015
Q1
– Sell
-900
Closed -$14K – 318
2014
Q4
$14K Buy
+900
New +$12.8K ﹤0.01% 310

Other funds holding INSM

Picton Mahoney Asset Management's INSM Position: Q1 2026 in Review

Picton Mahoney Asset Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 57,259 shares — an estimated $9.97M sold.

Picton Mahoney Asset Management first reported a position in INSM in Q4 2014 and held it in 8 quarters. The position peaked at $9.97M in Q4 2025. 675 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Picton Mahoney Asset Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 57,259 Insmed shares in Q1 2026, an estimated $9.97M.
  • Picton Mahoney Asset Management first reported a position in Insmed in Q4 2014 and held it in 8 quarters.
  • Picton Mahoney Asset Management's Insmed position peaked at $9.97M in Q4 2025.
  • 675 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.